“…However, logistical and ethical difficulties in performing such studies using human fetal tissue have led to the search for more amenable cell preparations that could be standardized for quality, safety and functionality, prior to clinical use in PD. Human mDA neurons have been generated from multiple cell types in vitro, including neural stem/progenitor cells (NS/PCs) (Maciaczyk et al, 2008;Riaz et al, 2002;Ribeiro et al, 2012;Sanchez-Pernaute et al, 2001), pluripotent stem cells (PSCs) (Denham et al, 2012;Grealish et al, 2014;Kirkeby et al, 2012;Kriks et al, 2011;Xi et al, 2012) and by lineage reprogramming of somatic cells such as fibroblasts (Caiazzo et al, 2011;Kim et al, 2011;Pfisterer et al, 2011). The in vivo functional capacity of PSC-derived mDA cells has recently been found to match that of fetal tissue (Grealish et al, 2014).…”